Literature DB >> 973819

Visual effects of pilocarpine in glaucoma comparative study of administration by eyedrops or by ocular therapeutic systems.

H S Brown, G Meltzer, R C Merrill, M Fisher, C Ferré, V A Place.   

Abstract

Eighteen glaucoma patients each received four pilocarpine regimens in random sequence: 1% and 4% eyedrops and 20mug/hr and 40mug/hr ocular therapeutic systems. Unimportant changes in refraction, near vision, and distance vision occurred during the use of either ocular therapeutic system. Miosis with ocular therapeutic systems was almost always less intense and variable than with eyedrops. Refractive changes occurred in 12 patients following 1% pilocarpine and in 16 patients following 4% pilocarpine drops; decreased distance vision occurred in nine patients after 1% drops and in 12 patients after 4% drops. Fewer patients showed decreases in near vision. In all cases, visual effects peaked one half hour after eyedrop instillations and returned gradually toward normal in the next two to three hours. Intraocular pressure levels were within comparable ranges during all four treatments, but the ocular therapeutic systems maintained pressure at a more constant level.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 973819     DOI: 10.1001/archopht.1976.03910040490004

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Comparison of the pupillary, refractive, and hypotensive effects of Ocusert-40 and pilocarpine eyedrops in the treatment of chronic simple glaucoma.

Authors:  S E Smith; S A Smith; A I Friedmann; J M Chaston
Journal:  Br J Ophthalmol       Date:  1979-04       Impact factor: 4.638

2.  Controlled delivery of pilocarpine. 1. In vitro characterization of Gelfoam matrices.

Authors:  S R Nadkarni; S H Yalkowsky
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

Review 3.  Rate-controlled drug dosage.

Authors:  J Urquhart
Journal:  Drugs       Date:  1982-03       Impact factor: 9.546

4.  Ocular absorption and irritation of pilocarpine prodrug is modified with buffer, polymer, and cyclodextrin in the eyedrop.

Authors:  P Suhonen; T Järvinen; K Lehmussaari; T Reunamäki; A Urtti
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

5.  Piloplex, a new long-acting pilocarpine polymer salt. B: Comparative study of the visual effects of pilocarpine and Piloplex eye drops.

Authors:  Z Mazor; U Ticho; U Rehany; L Rose
Journal:  Br J Ophthalmol       Date:  1979-01       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.